Format

Send to

Choose Destination
Eur J Oncol Nurs. 2008 Sep;12(4):357-61. doi: 10.1016/j.ejon.2008.07.003.

European Oncology Nursing Society extravasation guidelines.

Author information

1
University of Stirling, Department of Nursing and Midwifery, Cancer Care Research Centre, Scotland. Yvonne.wengstrom@ki.se

Abstract

An infrequent, but potential complication of chemotherapy is vesicant chemotherapy extravasation. Vesicants have the potential to cause blistering and ulceration when they extravasate from the vein or are inadvertently administered into the tissue. In 2007, the European Oncology Nursing Society published guidelines for extravasation prevention, detection, and management. Recommended management includes topical heating for plant alkaloid extravasations and topical cooling for anthracycline and other antitumor antibiotic vesicants. For treatment of antracycline extravasations topical dimethylsulfoxide (DMSO), sodium thiosulfate, and hyaluronidase have been described in the literature but due to lack of evidence to support their use as vesicant extravasation antidotes, it is recommended that these agents are studied further. Furthermore, Savene (dexrazoxane) is the only registered drug for the treatment of antracycline extravasation. Nurses need to be aware of current evidence-based guidelines for detecting and managing vesicant extravasations and need to be prepared to administer evidence-based treatment.

PMID:
18765210
DOI:
10.1016/j.ejon.2008.07.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center